- Home
- INO vs LRFC Comparison
INO vs LRFC Comparison
Compare INO & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- LRFC
- Stock Information
- Founded
- INO 1979
- LRFC 2013
- Country
- INO United States
- LRFC United States
- Employees
- INO N/A
- LRFC N/A
- Industry
- INO Medical/Dental Instruments
- LRFC Finance: Consumer Services
- Sector
- INO Health Care
- LRFC Finance
- Exchange
- INO Nasdaq
- LRFC Nasdaq
- Market Cap
- INO 75.4M
- LRFC 68.2M
- IPO Year
- INO 1998
- LRFC 2013
- Fundamental
- Price
- INO $2.08
- LRFC $23.92
- Analyst Decision
- INO Buy
- LRFC
- Analyst Count
- INO 6
- LRFC 0
- Target Price
- INO $17.00
- LRFC N/A
- AVG Volume (30 Days)
- INO 1.2M
- LRFC 6.4K
- Earning Date
- INO 03-05-2025
- LRFC 03-12-2025
- Dividend Yield
- INO N/A
- LRFC 5.60%
- EPS Growth
- INO N/A
- LRFC N/A
- EPS
- INO N/A
- LRFC N/A
- Revenue
- INO $203,413.00
- LRFC $19,936,000.00
- Revenue This Year
- INO N/A
- LRFC $3.63
- Revenue Next Year
- INO $2,290.97
- LRFC N/A
- P/E Ratio
- INO N/A
- LRFC N/A
- Revenue Growth
- INO N/A
- LRFC N/A
- 52 Week Low
- INO $1.74
- LRFC $20.65
- 52 Week High
- INO $14.75
- LRFC $26.00
- Technical
- Relative Strength Index (RSI)
- INO 39.63
- LRFC 38.64
- Support Level
- INO $1.83
- LRFC $23.78
- Resistance Level
- INO $2.39
- LRFC $24.80
- Average True Range (ATR)
- INO 0.17
- LRFC 0.51
- MACD
- INO 0.11
- LRFC -0.07
- Stochastic Oscillator
- INO 51.56
- LRFC 20.59
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.